1-833-323-JOIN research@lmcmanna.com
  • Facebook
  • Twitter
  • Facebook
  • Twitter
  • Join us – Participate in a Study!
LMC Manna Research - Diabetes Clinical Research Trials in Canada
  • About
  • Services
  • Specialties
  • Site Locations
  • Investigators
  • Research Team
  • Partners
  • News
  • Let’s Talk
Select Page
RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes

RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes

by LMC Manna Research | Feb 1, 2019 | Uncategorized

With one month of 2019 already completed, we are excited to share a 2nd FIT published paper from LMC Manna Research’s very own Scientist Team led by Chief Medical Officer Dr. Ronnie Aronson and Senior Scientist Michael Riddell. This 2nd paper highlights that High...
RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study

RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study

by LMC Manna Research | Nov 23, 2018 | News, Research

On Monday November 19th, LMC Manna Research’s own Type 1 Diabetes & Exercise study was published in Diabetes Care. The FIT Study is one of the most complex and impactful studies that LMC Manna Research’s own research team of endocrinologists,...

SCRS Webinar Spotlight – Stepping out of the box: Clinical Site Operations, Recruitment & Compliance

by LMC Manna Research | Oct 26, 2018 | News, Research

In May of 2018, LMC Manna Research’s own Karri Venn (President, Research) & Nazneen Qureshi (Manager, Patient Engagement & Clinical Projects) partnered with The Society for Clinical Research Sites (SCRS) as part of their webinar series Stepping out of...
Manuscript Accepted: SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes

Manuscript Accepted: SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes

by LMC Manna Research | Sep 25, 2018 | Uncategorized

LMC Healthcare & LMC Manna Researches own Drs. Ronnie Aronson, Harpreet Bajaj, and Ruth Brown‘s manuscript titled “SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes” has been accepted to...

Beyond Informed Consent — How To Better Engage Millennials (And Others) In Clinical Trials

by LMC Manna Research | Sep 25, 2018 | Uncategorized

Guest Columnists: Nazneen Qureshi, Manager, Patient Engagement, LMC Manna Research & Mary K.D. D’Rozario, President, Clinical Research Performance, Inc. Millennials aren’t kids any more — as the oldest members of the generation enter their 40s, they are a...
« Older Entries

LMC|Manna Research is the largest network of fully-owned and integrated clinical research sites in Canada providing Phase I-IV clinical trial services.

News

  • RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes
  • RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study
  • SCRS Webinar Spotlight – Stepping out of the box: Clinical Site Operations, Recruitment & Compliance

Contact Us

research@lmcmanna.com

1-833-323-JOIN

  • Home
  • Services
  • Specialties
  • Site Locations
  • Investigators
  • Research Team
  • Partners
  • Privacy Policy
  • Facebook
  • Twitter

Designed by Elegant Themes | Powered by WordPress